Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-02 Sale |
2025-01-03 7:33 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | NOUGUES MAXIMO F Chief Financial Officer |
10,227 | $3.1517 | $32,232 | 152,295 (Direct) |
View |
| 2025-01-02 Sale |
2025-01-03 7:31 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
9,437 | $3.1517 | $29,743 | 108,951 (Direct) |
View |
| 2025-01-02 Sale |
2025-01-03 7:28 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | HUNT DOUGLAS M See Remarks |
8,633 | $3.1517 | $27,209 | 124,594 (Direct) |
View |
| 2025-01-02 Sale |
2025-01-03 7:12 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | AUERBACH ALAN H President and CEO 10% Owner |
33,841 | $3.1517 | $106,657 | 7,029,674 (Direct) |
View |
| 2024-08-12 Sale |
2024-08-13 9:09 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | MILLER MICHAEL PATRICK Director |
23,358 | $3.4877 | $81,466 | 47,000 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-18 7:11 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | NOUGUES MAXIMO F Chief Financial Officer |
4,156 | $3.7011 | $15,382 | 162,522 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-18 7:06 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
2,598 | $3.7011 | $9,615 | 118,388 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-18 6:57 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | HUNT DOUGLAS M See Remarks |
3,637 | $3.7011 | $13,461 | 133,227 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-18 6:50 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | AUERBACH ALAN H President and CEO 10% Owner |
21,920 | $3.7011 | $81,128 | 7,063,515 (Direct) |
View |
| 2024-07-02 Sale |
2024-07-02 9:22 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | NOUGUES MAXIMO F Chief Financial Officer |
5,295 | $3.2685 | $17,307 | 166,678 (Direct) |
View |
| 2024-07-02 Sale |
2024-07-02 9:19 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
6,051 | $3.2685 | $19,778 | 120,986 (Direct) |
View |
| 2024-07-02 Sale |
2024-07-02 9:15 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | HUNT DOUGLAS M See Remarks |
4,349 | $3.2685 | $14,215 | 136,864 (Direct) |
View |
| 2024-07-02 Sale |
2024-07-02 9:10 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | AUERBACH ALAN H President and CEO 10% Owner |
18,885 | $3.2685 | $61,726 | 7,085,435 (Direct) |
View |
| 2024-06-13 Sale |
2024-06-17 7:27 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | WILSON TROY EDWARD Director |
27,000 | $3.3297 | $89,902 | 900 (Indirect Direct) |
View |
| 2024-06-13 Sale |
2024-06-17 7:25 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Stuglik Brian M Director |
9,900 | $3.3867 | $33,528 | 49,058 (Direct) |
View |
| 2024-06-13 Sale |
2024-06-17 7:23 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Senderowicz Adrian Director |
27,000 | $3.3266 | $89,818 | 0 (Direct) |
View |
| 2024-06-13 Sale |
2024-06-17 7:21 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | MOYES JAY M Director |
22,000 | $3.3394 | $73,467 | 21,322 (Direct) |
View |
| 2024-06-13 Sale |
2024-06-17 7:18 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Dorval Allison Director |
11,000 | $3.3724 | $37,096 | 33,000 (Direct) |
View |
| 2023-12-04 Sale |
2024-01-10 4:41 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Wong Alvin F Chief Scientific Officer |
280 | $3.7608 | $1,053 | 97,934 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-05 7:03 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Wong Alvin F Chief Scientific Officer |
7,733 | $4.4859 | $34,689 | 98,214 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-05 7:00 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
12,956 | $4.4859 | $58,119 | 99,970 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-05 6:56 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | AUERBACH ALAN H President and CEO 10% Owner |
41,396 | $4.4859 | $185,698 | 6,936,947 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-05 6:49 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | NOUGUES MAXIMO F Chief Financial Officer |
15,682 | $4.4859 | $70,348 | 128,666 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-07 Option Award |
2025-02-11 6:58 pm |
N/A 2035-02-06 |
PUMA BIOTECHNOLOGY INC. | PBYI | NOUGUES MAXIMO F Chief Financial Officer |
146,523 | $0 | 298,818 (Direct) |
View |
| 2025-02-07 Option Award |
2025-02-11 6:55 pm |
N/A 2035-02-06 |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
114,062 | $0 | 223,013 (Direct) |
View |
| 2025-02-07 Option Award |
2025-02-11 6:53 pm |
N/A 2035-02-06 |
PUMA BIOTECHNOLOGY INC. | PBYI | HUNT DOUGLAS M See Remarks |
114,721 | $0 | 239,315 (Direct) |
View |
| 2025-02-07 Option Award |
2025-02-11 6:51 pm |
N/A 2035-02-06 |
PUMA BIOTECHNOLOGY INC. | PBYI | AUERBACH ALAN H President and CEO 10% Owner |
473,021 | $0 | 7,502,695 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-21 9:27 pm |
N/A N/A |
PUMA BIOTECHNOLOGY INC. | PBYI | WILSON TROY EDWARD Director |
27,000 | $0 | 27,900 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-21 9:25 pm |
N/A N/A |
PUMA BIOTECHNOLOGY INC. | PBYI | Stuglik Brian M Director |
27,000 | $0 | 76,058 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-21 9:22 pm |
N/A N/A |
PUMA BIOTECHNOLOGY INC. | PBYI | Senderowicz Adrian Director |
27,000 | $0 | 27,000 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-21 9:21 pm |
N/A N/A |
PUMA BIOTECHNOLOGY INC. | PBYI | MILLER MICHAEL PATRICK Director |
27,000 | $0 | 95,358 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-21 9:19 pm |
N/A N/A |
PUMA BIOTECHNOLOGY INC. | PBYI | MOYES JAY M Director |
27,000 | $0 | 48,322 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-21 9:17 pm |
N/A N/A |
PUMA BIOTECHNOLOGY INC. | PBYI | Dorval Allison Director |
27,000 | $0 | 60,000 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-21 9:16 pm |
N/A N/A |
PUMA BIOTECHNOLOGY INC. | PBYI | Cesano Alessandra Director |
27,000 | $0 | 54,000 (Direct) |
View |
| 2024-03-15 Option Award |
2024-03-19 9:01 pm |
N/A 2034-03-14 |
PUMA BIOTECHNOLOGY INC. | PBYI | AUERBACH ALAN H President and CEO 10% Owner |
15,624 | $0 | 7,113,367 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 6:03 pm |
N/A 2034-02-11 |
PUMA BIOTECHNOLOGY INC. | PBYI | Wong Alvin F Chief Scientific Officer |
103,253 | $0 | 201,187 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 6:01 pm |
N/A 2034-02-11 |
PUMA BIOTECHNOLOGY INC. | PBYI | NOUGUES MAXIMO F Chief Financial Officer |
103,253 | $0 | 231,919 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 6:00 pm |
N/A 2034-02-11 |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
64,533 | $0 | 164,503 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 5:58 pm |
N/A 2034-02-11 |
PUMA BIOTECHNOLOGY INC. | PBYI | AUERBACH ALAN H President and CEO 10% Owner |
383,369 | $0 | 7,320,316 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 5:54 pm |
N/A 2034-02-11 |
PUMA BIOTECHNOLOGY INC. | PBYI | HUNT DOUGLAS M See Remarks |
90,346 | $0 | 193,665 (Direct) |
View |